FDA Medical devices recall ·

HemosIL SynthAFax recall

Recall number
Z-0938-2026
Date
(initiated November 18, 2025)
Company / brand
Instrumentation Laboratory
180 Hartwell Rd, Bedford, MA, United States
Category
Medical devices › Class III
Classification
Class III
Status
Ongoing
Units affected
4,506 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

HemosIL SynthAFax. Partial Thromboplastin Time Tests.

Why was it recalled?

Recalled lots were manufactured with double the amount of preservative concentration.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Part No. 0020007400; UDI: 08426950087649; Lot No. (Exp. Date) N0542231(2026-06-30), N0250088(2027-04-30, N0452249 (2027-06-30).

Distribution

Domestic: CA, CO, FL, NY; Foreign: AR, AT, CA, CZ, DE, DK, ES, FR, GB, IE, IL, IN, IT, JP, LK, NL, PL, PT, RO, RS, TH, VN.

States: Arkansas California Colorado Delaware Florida Illinois Indiana New York

What does Class III mean?

Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).

Source: FDA (medical devices), recall Z-0938-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.